Login
$NGNE
$26.99 +$3.45 (14.66%) Close

$NGNE 8-K/A SEC Filings

Filed On Filing
23 Jan 2023 8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year

Section 1.1: Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date and time as the Board of Directors (the “Board”) of Neoleukin Therapeutics, Inc. (the...

17 Dec 2019 8-K/A: Financial Statements and Exhibits
11 Oct 2019 8-K/A: Financial Statements and Exhibits
07 Aug 2015 8-K/A: Other Events

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support